New Lilly, BI diabetes med hits shelves; AstraZeneca launches online tool for docs;

> Eli Lilly ($LLY) and Boehringer Ingelheim's new Type 2 diabetes treatment Jardiance is now available in U.S. pharmacies. Release

> AstraZeneca ($AZN) has launched a new online tool in the U.S. to help medical professionals keep better up to date with their areas of study. More

> Valeant Canada has acquired Valeo Pharma's dermatology product portfolio and several specialty products. Release | Report

> Copenhagen has become the second city involved in Novo Nordisk's ($NVO) global "Cities Changing Diabetes" campaign. Story

> Mylan ($MYL) chose three kids with potentially life-threatening allergies to join NFL star Adrian Peterson to film an educational video about anaphylaxis. Release

And Finally... Merck ($MRK) has started the second year of a 5-year project to fight diabetes by supporting E-Learning in Africa. More

Suggested Articles

Cardiac risks associated with roxadustat are comparable to placebo in nondialysis patients and to Amgen's standard, Epogen, in those on dialysis.

Pfizer and Merck KGaA's immuno-oncology agent Bavencio failed another gastric cancer study, this time as a maintenance treatment after chemotherapy.

A jury ordered Biogen to pay nearly $6 million to a former sales manager who reported a colleague's misconduct and got fired a few months later.